Prelude Therapeutics Incorporated
PRLD
$3.94
$0.102.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -20.99% | 87.81% | -24.94% | -26.10% | -25.85% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 22.64% | -26.53% | -7.84% | 9.94% | 45.94% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -19.96% | 81.20% | -24.12% | -24.93% | -24.65% |
|
|
|||||
| Total Current Assets | -19.96% | 81.20% | -24.12% | -24.93% | -24.65% |
| Net Property, Plant & Equipment | -2.41% | -2.42% | -2.38% | -2.35% | -2.15% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.10% | 0.00% | -19.48% | 0.00% | 0.00% |
| Total Assets | -15.34% | 49.14% | -17.55% | -18.65% | -19.52% |
|
|
|||||
| Total Accounts Payable | -48.05% | 57.24% | -48.95% | -14.90% | -24.59% |
| Total Accrued Expenses | -56.54% | -3.33% | -3.29% | 16.66% | -26.53% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.62% | 0.62% | 0.59% | 2.19% | -1.74% |
| Total Finance Division Other Current Liabilities | -8.17% | 3,503.22% | 11.85% | 23.71% | -9.73% |
| Total Other Current Liabilities | -8.17% | 3,503.22% | 11.85% | 23.71% | -9.73% |
| Total Current Liabilities | -21.27% | 191.34% | -13.00% | 5.67% | -22.83% |
|
|
|||||
| Total Current Liabilities | -21.27% | 191.34% | -13.00% | 5.67% | -22.83% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -0.56% | -0.54% | -0.52% | -0.40% | -0.38% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -40.09% | 59.75% | -2.09% | -2.05% | -2.01% |
| Total Liabilities | -18.19% | 100.65% | -7.32% | 2.62% | -13.56% |
|
|
|||||
| Common Stock & APIC | 0.26% | 3.66% | 0.33% | 0.54% | 0.54% |
| Retained Earnings | -1.52% | -2.47% | -3.05% | -5.07% | -5.50% |
| Treasury Stock & Other | -612.50% | 300.00% | 300.00% | -108.33% | -65.71% |
| Total Common Equity | -12.32% | 17.26% | -22.82% | -26.50% | -21.51% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -12.32% | 17.26% | -22.82% | -26.50% | -21.51% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -12.32% | 17.26% | -22.82% | -26.50% | -21.51% |
|
|
|||||